You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

High Risk (HR) HPV

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Human Papillomavirus Trial in Toulouse (Smear)

Recruiting
  • Human Papillomavirus
  • Smear
  • Toulouse, France
    CHU Toulouse
Jul 18, 2022

Human Papilloma Virus Trial in Vallecas (Colpofix)

Not yet recruiting
  • Human Papilloma Virus
  • Colpofix
  • Vallecas, Madrid, Spain
    Hospital Universitario Infanta Leonor
Jun 7, 2021

Human Papilloma Virus Infection Trial in Jakarta (HPV Diagnostic Kit (Bio Farma))

Completed
  • Human Papilloma Virus Infection
  • HPV Diagnostic Kit (Bio Farma)
  • Jakarta, DKI Jakarta, Indonesia
    Cipto Mangunkusumo Hospital
Oct 26, 2023

HPV-Related Cervical Carcinoma, Low-Grade Squamous Intraepithelial Lesions, HPV Infection Trial in Wenzhou (CO2)

Recruiting
  • HPV-Related Cervical Carcinoma
  • +3 more
  • CO2
  • Wenzhou, Zhejiang, China
    first affiliated hospital of Wenzhou medical university
Sep 23, 2023

Cervix Dysplasia, HPV Infection Trial in Herne (DEFLAGYN vaginal gel)

Not yet recruiting
  • Cervix Dysplasia
  • HPV Infection
  • DEFLAGYN vaginal gel
  • Herne, North Rhine-Westphalia, Germany
    Marien Hospital Herne
Aug 19, 2022

Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC) Trial (Monalizumab, Cetuximab)

Not yet recruiting
  • Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)
  • Monalizumab
  • Cetuximab
  • (no location specified)
Jan 8, 2023

Breast Cancer Trial in Ann Arbor (Ribociclib, Postoperative Radiation Therapy)

Not yet recruiting
  • Breast Cancer
  • Ann Arbor, Michigan
    University of Michigan
Aug 10, 2023

Papilloma Viral Infection, CIN1, LSIL, Low Grade Squamous Intraepithelial Lesion Trial in Madrid (Glizigen, Placebo)

Recruiting
  • Papilloma Viral Infection
  • +2 more
  • Glizigen
  • Placebo
  • Madrid, Spain
  • +3 more
Jun 27, 2023

HPV Infection Trial in H?i Phòng (Gardasil®, Merck)

Active, not recruiting
  • HPV Infection
  • Gardasil®, Merck
  • Hải Phòng, Vietnam
    Hai Phong District Health Centre
Sep 20, 2022

Oropharynx Squamous Cell Carcinoma Trial in Ann Arbor (Nivolumab, Carboplatin, Paclitaxel)

Active, not recruiting
  • Oropharynx Squamous Cell Carcinoma
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Dec 20, 2022

HPV Integration on the Prognosis of Persistent HR-HPV Infection

Recruiting
  • HPV Infection
  • +3 more
  • Follow up
  • Fuzhou, Fujian, China
  • +10 more
Mar 7, 2022

HPV in Sinonasal Ca: Retrospective Analysis Association of Human

Recruiting
  • Sinonasal Carcinoma
  • HPV-Related Squamous Cell Carcinoma
    • Baltimore, Maryland
      Johns Hopkins University
    Jul 28, 2022

    Cervical Cancer, Prevention Trial in Ramotswa (Automated visual evaluation)

    Active, not recruiting
    • Cervical Cancer
    • Prevention
    • Automated visual evaluation
    • Ramotswa, Botswana
      Bamalete Lutheran Hospital
    Feb 1, 2023

    Breast Cancer Trial (Patritumab deruxtecan, Chemotherapy, Letrozole)

    Recruiting
    • Breast Cancer
    • Patritumab deruxtecan
    • +2 more
    • Barcelona, Spain
      Hospital Clinic de Barcelona
    Nov 28, 2022

    Acute Myeloid Leukemia, Myelodysplastic Tumor Trial (Magrolimab, 7+3, CPX-351)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Neoplasm
    • (no location specified)
    Apr 24, 2023

    Acromegaly: Balance, Falls and Fracture Risk

    Not yet recruiting
    • Acromegaly
    • HR-pQCT
    • +7 more
    • Aalborg, North Denmark Region, Denmark
      Aalborg University Hospital
    Mar 3, 2023

    HPV Infection Trial (Human interferon alpha 2b vaginal Effervescent capsules)

    Not yet recruiting
    • HPV Infection
    • Human interferon alpha 2b vaginal Effervescent capsules
    • (no location specified)
    May 8, 2023

    ctDNA and/or HPV DNA in High-risk Locally-advanced Head and Neck

    Active, not recruiting
    • Cancer
    • +2 more
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      Apr 7, 2022

      Hpv, HPV 16 Infection, HPV Infection Trial in United States (Teal Wand Self-Collection Device Group)

      Not yet recruiting
      • Hpv
      • +3 more
      • Teal Wand Self-Collection Device Group
      • Birmingham, Alabama
      • +12 more
      Nov 1, 2023

      Locally Advanced Breast Cancer, Hormone Receptor Positive,HER2-negative Breast Cancer Trial in Jinan (letrozole)

      Recruiting
      • Locally Advanced Breast Cancer
      • Hormone Receptor Positive，HER2-negative Breast Cancer
      • Jinan, Shandong, China
        Breast Cancer Center, Shandong Cancer Hospital and Institute
      Apr 11, 2023

      Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III), Human Papillomavirus (HPV) Infections, High-risk HPV Trial

      Recruiting
      • Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III)
      • +3 more
      • Nonavalent HPV vaccine (9vHPV/Gardasil-9™).
      • L'Hospitalet De Llobregat, Catalunya, Spain
        Gynaecology Unit, Bellvitge University Hospital (HUB)
      Jan 24, 2023

      Neuroblastoma Trial in Cologne (antibody ch14.18, GM-CSF, IL-2 i.v.)

      Terminated
      • Neuroblastoma
      • antibody ch14.18
      • +4 more
      • Cologne, Germany
        University of Cologne
      Nov 3, 2022

      Global Burden Estimation of Human Papillomavirus (GLOBE-HPV)

      Not yet recruiting
      • HPV Infection
      • Urine Sample Collection
      • +2 more
      • Dhaka, Bangladesh
      • +7 more
      Nov 10, 2023

      Type 1 Diabetes Trial in Aurora (Home Telehealth T1D C2oYoT1-HR, Personalized Behavioral Health, Personalized Adherence

      Completed
      • Type 1 Diabetes Mellitus
      • Home Telehealth T1D C2oYoT1-HR
      • +2 more
      • Aurora, Colorado
        Barbara Davis Center for Childhood Diabetes
      Jul 19, 2022

      Breast Cancer, Chemo Effect Trial (Capecitabine)

      Not yet recruiting
      • Breast Cancer
      • Chemotherapy Effect
      • (no location specified)
      Mar 9, 2022